FTC Urges 8th Circ. Not To Pause Insulin Pricing Case
By Matthew Perlman · March 14, 2025, 5:35 PM EDT
The Federal Trade Commission has urged the Eighth Circuit not to pause its in-house case accusing Caremark Rx, Express Scripts and OptumRx of artificially inflating insulin prices, telling the appeals court...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login